Delivery Order SPE2DR25D2005-SPE2DR26FE7T3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Fluorometholone 0.1% eye drops in 5ml units, with a contract ceiling value of $1,002.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Fluorometholone 0.1% eye drops in 10ml quantities, valued at $7,799.08 with a firm fixed price structure. This non-set-aside, competitively awarded contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. The award represents a child delivery order under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluorometholone 0.1% eye drops (5mL) valued at $1,068.37. This competitively awarded, firm fixed-price contract was delivered to the company's Conshohocken, Pennsylvania facility on November 24, 2025, with an ultimate completion date of November 25, 2025. The contract represents a small-value transaction typical of AmerisourceBergen's extensive portfolio of pharmaceutical deliveries supporting federal...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 26, 2025, by the Defense Logistics Agency (DLA) for the supply of Fluorometholone 0.1% eye drops in a 5 mL unit, with a ceiling value of $2,763.79. This competitive award carries firm fixed pricing and is expected to be completed by August 27, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Fluorometholone 0.1% eye drops in 10 mL units, with a ceiling value of $9,834.86. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Fluorometholone 0.1% eye drops in 5ml units, with a contract ceiling value of $2,476.47. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Fluorometholone 0.1% eye drops in 5-milliliter quantities, with a ceiling value of $8,938.38. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by November 6, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Fluorometholone 0.1% Eye Drop in 5mL units, with a ceiling value of $2,748.36. This is a firm fixed price delivery order with no set-aside designation, executed as a competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $2,349.36 delivery order to AmerisourceBergen Drug Corp for Fluorometholone 0.1% eye drops (10 mL) on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Fluorometholone 0.1% eye drops (10ML) with a contract ceiling value of $18,598.32. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7T3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Fluorometholone 0.1% eye drops in 5 mL quantities, valued at $8,807.49 with a firm fixed price structure. This contract, designated as a non-set-aside competitive award, is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order supports the DLA's medical supply chain requirements for pharmaceutical products across military and federal healthcare systems. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal healthcare vendor, fulfills these procurement needs through its comprehensive IDC vehicle, which enables the company to deliver a broad range of pharmaceutical products including specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains. The award is scheduled for ultimate completion by December 1, 2025, demonstrating the expedited nature of this specific pharmaceutical delivery within the company's larger framework of federal medical supply support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 11/27/25 |